TCS Collaborates With Roche
TCS has entered into a collaboration with Swiss healthcare company Roche to provide services related to drug development processes.
Tata Consultancy Services (TCS) has entered into a multi-year collaboration with Swiss healthcare company Roche to provide services related to drug development processes.
The collaboration with Roche will cover clinical data management, clinical programming, biostatistics and drug safety support as a part of the multinational’s Global Capacity Building Initiative (GCBI).
“This is the first such end-to-end deal we have done,” TCS executive vice-president and global head (life sciences and healthcare) J Rajagopal said.
According to Jean-Jacques Garaud, Roche global head (pharma development), “The partnership with TCS will allow us to address the growing operational needs of our development organisation and to handle the increasing workload.”
The Global Capacity Building Initiative programme will be staffed by doctors, pharmacologists, physicians, biostatisticians, pharmacists and informatics specialists. The operations would be handled initially from Mumbai and can expand to other cities later.

Future Group - Reliance Retail Deal approved by CCI
RBI ban on cryptocurrencies takes effect; prohibition could force investors to tap the black market
Petrol, diesel rates: Fuel prices reduced for sixth day in a row amid lower Brent futures
IT firms will have to re-skill two million employees ahead of a full-blooded digital push; are they prepared?
Flipkart shareholders barring SoftBank Group agree to sell stake to US retail giant Walmart

